GMAB
Genmab is an international biotechnology company focused on creating and developing antibody therapeutics to treat cancer and other serious diseases. The company emphasizes pioneering antibody science and proprietary technologies to advance next-generation medicines, with a global presence including regional sites in Japan and the United States. Genmab emphasizes collaborations with healthcare professionals, patients, and partners to transform patient outcomes and drive innovation in oncology and related fields. Its mission includes incorporating patient perspectives and sustainable practices across its research, development, and corporate activities.
No recent deals for this company.